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Objective The aim of this study is to identify items of economic
evaluation guidelines that are frequently not complied within
obstetric economic evaluations and to search for reasons for non-
adherence.
Design Scoping review and qualitative study.
Setting Literature on economic evaluations in obstetric care and
interviews with experts.
Population or sample The sample included 229 scientific articles
and five experts.
Methods A systematic literature search was performed. All types
of literature about economic evaluations in obstetric care were
included. The adherence to guidelines was assessed and articles
were qualitatively analysed on additional information about
reasons for non-adherence. Issues that arose from the scoping
review were discussed with experts.
Main outcome measures Adherence to guideline items of the
included economic evaluations studies. Analytical themes
describing reasons for non-adherence, resulting from qualitative
analysis of articles and interviews with experts.
Results A total of 184 economic evaluations and 45 other type of
articles were included. Guideline items frequently not complied
with were time horizon, type of economic evaluation and effect
measure. Reasons for non-adherence had to do with paucity of
long-term health data and assessing and combining outcomes for
mother and child resulting from obstetric interventions.
Conclusions This study identified items of guidelines that are
frequently not complied with and the reasons behind this. The
results are a starting point for a broad consensus building on how
to deal with these challenges that can result in special guidance
for the conduct of economic evaluations in obstetric care.
Keywords Economic evaluation, guidelines, obstetric care,
scoping review.
Tweetable abstract Non-adherence to guidelines in obstetric
economic evaluation studies: the difficulties in detail.
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Introduction
During the last decades, healthcare professionals have been
increasingly confronted with rising costs and limited
resources. Although new and improved medical interven-
tions can improve health outcomes, resources are scarce,
and it is becoming increasingly important for policy mak-
ers to make informed decisions on how to spend these
resources.
Economic evaluations (EE) provide a framework to com-
pare healthcare interventions in terms of both costs and
health outcomes with a relevant comparator, such as stan-
dard care. This information can be used by policy makers
to decide which interventions maximise total health gains
given the scarce resources.1
Because these EEs inform such important decisions,
many countries have developed guidelines on how to per-
form them.2–5 These guidelines typically use a reference
case to illustrate the main methodological prescriptions
which should be adhered to when conducting an EE. The
standardisation of methods for EEs is aimed at increase the
quality and comparability of the methods across studies,
which facilitates decision making.
Guidelines contain recommendations about important
characteristics of an EE, such as the viewpoint from which
the study is conducted (perspective), the period of time for
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which cost and effects are assessed, from the beginning of
observation to a defined point of time in the future (time
horizon) and effect measure. The recommendations apply
to healthcare interventions in general. These healthcare
interventions, however, are very heterogeneous and, for
some, the recommendations may be difficult to comply
with.
Previous reviews of EE studies in gynaecology and
obstetrics, reported problems with adherence to guideli-
nes,6,7 although improvement over time has been
observed.8,9 However, it was still concluded that improve-
ment of the methodological quality of EEs within the
field of obstetrics and gynaecology remained possible and
desirable.
Obstetric care has multiple unique features creating
methodological challenges in EE. Examples are the combi-
nation of the outcomes for mother and child and the
assessment of potential long-term consequences of inter-
ventions. These challenges could lead to non-adherence
with standard guidelines. It is currently unclear whether, in
obstetrics, researchers deliberately deviate from existing
guidelines in order to improve the relevance of their analy-
sis, or they simply fail to comply with the standards for
EEs without justification.
The goal of this scoping review of obstetric EEs therefore
is to identify items of guidelines frequently not complied
with and reasons for such non-adherence. We focus on the
effect side of EEs.
Methods
Scoping review
A scoping review was performed10 focusing on literature
about EEs on interventions directly related to individual
obstetric care for women with an ongoing pregnancy, pub-
lished from the year 2000 onwards. Due to the broad scope
of our review, we comprehensively included all types of lit-
erature potentially suitable for answering the research ques-
tion, including EEs, comments, editorials, letters and
reviews.
In March 2018, a systematic search was performed in
four electronic databases (PubMed, Embase, Web of
Science, Cochrane Library) (see Appendix S1). Titles
and abstracts were screened according to the criteria
listed in Appendix S2. A random sample of 100 articles
was screened on titles and abstracts by two authors
(SH, MA), resulting in strong agreement. Any disagree-
ments during this process were resolved by discussion.
Remaining articles were screened by a single author
(SH). In case of doubt, two authors (SH and MA) dis-
cussed the article and decided together on inclusion or
exclusion.
Data extraction
Articles were labelled as ‘economic evaluation’, ‘comment/
editorial/letter’ or ‘review’. Data extracted from the EEs
considered items (see Table 1 for definitions) that are
part of reference cases in international guidelines
(Appendix S3): the viewpoint from which the study is con-
ducted (perspective), comparator, type of economic evalua-
tion (analytical technique), time horizon, outcome measure
used (effects), converting future costs and effects to their
present value (discounting) and dealing with unknown
information needed for the evaluation (uncertainty). In
Appendix S3, guidelines from the Netherlands, UK and
USA, the countries from which the majority of the EEs
included in this study originate, and a general guideline of
Europe2–5 are presented as an example of what most guide-
lines look like. Most guidelines recommend the same items,
although the content of recommendations can differ.11
The item ‘costs’ was excluded as the methodological
choices made on this item were considered less informative
for the current study (as being less obstetrics-specific or a
consequence of other choices, such as perspective).
The EEs and other type of articles were also screened for
specific information or argumentation about (non-)adher-
ence to guidelines and reasons behind the methodological
choices made. General limitations were not extracted for
qualitative analysis, as our aim was to detect specific chal-
lenges for EEs in the field of obstetrics.
Qualitative analysis of the retrieved data was done
according to the ‘thematic synthesis’ method,12 involving
three steps. Step 1 comprises free line-by-line coding of the
findings of primary studies, which means that each line of
text is scrutinised for relevant information and subse-
quently coded according to its meaning and content. Step
2 involves the organisation of these ‘free codes’ into related
areas to construct ‘descriptive’ themes. These themes sum-
marise the main subject of the codes, but still stay close to
the original content of the data. Step 3 generates analytical
themes by identifying underlying themes.12 The analytical
themes were considered the core outcome of the qualitative
analysis.
Interviews with experts
Subsequently, semi-structured interviews were held with
international experts in the field of EE within obstetric
care. The experts could be considered a convenience sam-
ple. We approached 10 experts, who were either health
economists in the field of obstetrics or obstetricians with
experience in health economics. Five of them agreed to
participate. These experts elaborated on the analytical
themes derived from the qualitative analysis. After briefly
introducing each analytical theme, experts were encouraged
to elaborate on possible solutions for non-adherence to
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guidelines (see interview format in Appendix S4). The
interviews were recorded and transcribed. Analysis of the
interviews was also performed according to the ‘thematic
synthesis’ method.
Due to the methodological nature of this study, no
patient public involvement took place. We did not apply
for funding for this study.
Results
Items of the guidelines most frequently not
complied with
The systematic literature search in the scoping review part
of this study resulted in 2811 articles considered eligible for
screening. We excluded 2474 articles based on title and
abstract. The remaining 337 articles were included for full-
text reading. Their references were screened for additional
articles (‘snowballing’), which resulted in one additional
included article. A total of 229 articles were included for
final analysis, including 184 EEs, 25 comments, editorials
or letters, and 20 (systematic) reviews (see Figure S1). Of
the 184 EEs, 40 were trial-based (TBEE) (n = 36) or cohort
studies (n = 4), and 144 were model-based (MBEE). Most
studies originated from the USA (n = 88), followed by the
UK (n = 37), the Netherlands (n = 23), other European
countries (n = 15), Australia and New Zealand (n = 14),
and Canada (n = 7). Interventions included screening/diag-
nostics (n = 60), maternal vaccination (n = 14), lifestyle
intervention (n = 12), treatment for maternal disease
(n = 15), treatment for fetal disease during pregnancy
(n = 3), treatment for pregnancy-related pathophysiology
(n = 27) and interventions related to labour and delivery
(n = 53).
Table 2 presents the results on methodological choices
separately for TBEE and MBEE. We found a wide variety
in methodological choices and low adherence to the guide-
lines for all items except ‘perspective’ and ‘uncertainty’.
The low adherence rate for ‘comparator’ was mostly due to
a lack of detailed reporting. For example, a lot of articles
explained their comparator but did not refer to it as ‘stan-
dard care’. We could not link this low adherence to special
features of obstetric care. The same goes for ‘discounting’;
Table 1. Definitions of concepts in economic evaluations
Concepts Definition
Economic evaluation (EE) The comparative analysis of two or more health interventions in terms of both their costs and consequences.
Basic tasks of any economic evaluation are to identify, measure, value and compare costs and consequences of
the alternatives being considered
Model-based economic
evaluation (MBEE)
Economic evaluation based on using a model which integrates data from multiple sources
Trial-based economic
evaluation (TBEE)
Economic evaluation conducted alongside a randomised controlled trial (RCT)
Cost-effectiveness analysis
(CEA)
Compares difference in costs of two or more health interventions with the difference in effects. Effects are
expressed in a single natural unit, such as ‘neonatal infection prevented’ or ‘preterm birth prevented’
Cost-utility analysis (CUA) Compares difference in costs of two or more health interventions with the difference in effects. Effects are
expressed in quality-adjusted life-years (QALYs)
Quality-adjusted life-year
(QALY)
QALYs measure health as a function of quality of life and length of life. A life-year lived in full health is equal
to 1 QALY
Utility values The quality of life is expressed in a utility value, belonging to a certain health state. Utility values of health
states range between ‘1’ (full health) and ‘0’ (death) and can be determined by using standardised
questionnaires on quality of life, such as the EQ-5D
EuroQoL-5 Dimensions (EQ5D) A standardised questionnaire to measure health-related quality of life
Perspective Viewpoint from which the economic evaluation study is conducted (e.g. healthcare perspective or societal
perspective)
Comparator The most used alternative or current practice (usual care)
Time horizon The period of time for which cost and effects are assessed, from the beginning of observation to a defined
point of time in the future
Effect measure Measure for the effect of the intervention, e.g. natural units (avoided infections) in CEAs or QALYs in CUAs
Discounting Converting future costs and effects to their present value
Uncertainty analysis Uncertainty analysis aims at quantifying the sensitivity of the outcome of EE that is due to the uncertainty of
the information included in the EE
Reference case Used by guidelines to illustrate the main methodological prescriptions which should be adhered to when
conducting an economic evaluation
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Table 2. Methodological choices of included economic evaluations (n = 184)
Item Methodological choice TBEE
(n = 40)
MBEE
(n = 144)
Total %
adherencea
(n = 184)
n % n % n %
Type of analysis Cost-effectiveness 31 78 52 36 53
Cost-utility 3 8 79 55 82
Cost-consequence 2 5 — —
Cost-effectiveness and cost-utility 3 8 13 9 16
Cost-effectiveness and cost-consequence 1 2 — —
Perspective Healthcare 25 63 62 43 87 94
Societal 5 13 51 35 56
Hospital 4 10 3 2
Third party/healthcare payer 1 3 18 13 19
Healthcare and societal 5 13 3 2 8
Third party/healthcare payer and societal — — 3 2 3
Unclear — — 4 3
Comparator Standard care 24 60 92 64 116 63
Not referred to standard care, but specified 9 23 38 26
Placebo 5 13 1 1
Unclear 2 5 13 9
Time horizonb Short-term ≤1 year 78 36 25 49
Mid-term (>1 year, < lifetime) 6 15 9 6
Lifetime maternal — — 14 10 14
Lifetime neonatal — — 48 33 48
Lifetime maternal and neonatal — — 27 19 27
Combination of lifetime and short-term — — 1 1 1
Unclear 3 8 9 6
Effect measure 54
Maternal Maternal natural unitsc, life-years or HrQoLe 19 48 13 9
Maternal QALYsd 3 8 20 14 23
Maternal QALYsd and natural units or life-years 1 3 2 2 3
Neonatal Neonatal natural units and/or life-years 7 18 27 19
Neonatal QALYsd — — 30 21 30
Neonatal QALYsd, natural units and/or life-years 1 3 8 6 9
Maternal and neonatal Maternal and neonatal natural units, life-years and/or HrQoLe 8 20 12 8
Maternal and neonatal QALYsd — — 28 19 28
Maternal and neonatal natural units and neonatal QALYsd — — 2 1 2
Maternal natural units and neonatal QALYsd — — 1 1 1
Maternal QALYsd, maternal and neonatal natural units 1 3 — — 1
Maternal, neonatal and future offspring QALYsd — — 1 1 1
Discounting Yes, costs and effects equal — 67 47 67 58
Yes, costs and effects unequal — 11 8 11
Yes, but only reported costs or effects 3 8 22 16
Yes, but unclear — 1 1
Not, because of short time horizon or other reasons 15 38 13 9 28
Not reported 22 55 30 21
Uncertainty Deterministic univariate and/or multivariate 21 53 61 42 82 94
Probabilistic (only or combined with deterministic) 2 5 81 57 83
Yes, but unclear 8 20 — — 8
Not reported 9 23 2 1
a
Grey-shaded methodological choice is in accordance with one or more guidelines.
b
All guidelines mention that the time horizon should be long enough to capture all relevant differences between costs and effects.
c
Effects are expressed in a single natural unit, which represents the core medical outcome of a medical trial, such as ‘preterm birth prevented’.
d
Quality-adjusted life-years.
e
Health-related quality of life.
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when the duration of follow up does not exceed 1 year,
there is no need for discounting.
Only 15% of the TBEEs and 64% of the MBEEs per-
formed a cost-utility analysis (CUA) as recommended by
the guidelines (53% of the total included studies). CUAs
are economic evaluations with quality-adjusted life years
(QALYs) as outcome measure. QALYs are determined by
multiplying the quality of life (the utility value associated
with a health state) by the time spend in that health
state. Utility values of health states range between ‘1’
(full health) and ‘0’ (death) and can be determined using
standardised questionnaires about quality of life, such as
the EuroQoL-5 Dimensions (EQ-5D). Therefore, this
deviation from the guideline for ‘type of analysis’ also
translates into a deviation for effect measures. In TBEEs
in particular, the recommended QALYs were rarely used
as outcome measures.
Our results show that none of the TBEEs had a lifetime
horizon and 63% of the MBEEs adopted a lifetime horizon
(53% of the total included studies). Guidelines recommend
a lifetime horizon, i.e. cost and effects resulting from the
intervention during the whole lifetime should be included,
but leave room for other time horizons if well-argued
reasons are provided. In four studies, these reasons were
provided, increasing the adherence to guidelines to 5 and
64%, respectively.
Reasons for non-adherence: the analytical themes
after qualitative analysis
Screening on qualitative information about the method-
ological choices made, revealed that 70 articles (60 EEs, 5
comments/editorials/letters and 5 reviews) contained infor-
mation about (non-)adherence to guidelines, hence being
eligible for qualitative analysis.
Following the ‘thematic synthesis’ method, the qualita-
tive data from the EE studies led to two analytical themes,
which explain non-adherence to guideline recommenda-
tions on time horizon and type of analysis/effect measure
(Table 3):
 Difficulties using the correct time horizon, mainly due to
paucity of data on long-term health effects of perinatal
interventions.
 Difficulties in performing a CUA, mainly due to paucity
of health-related quality of life data for obstetric health
states and uncertainties in combining utility values for
mother and child.
Table 3. Analytical themes after qualitative analysis of included articles
Title of theme Example of coded information, extracted from included articles
1. Difficulties deciding on the correct time horizon, mainly due to
paucity of data on long-term health effects of perinatal
interventions
This study did not include longer-term outcomes for the offspring of
pregnant women diagnosed with GDM [gestational diabetes
mellitus] because of the paucity of evidence that would link GDM
and treatment of GDM to changes in longer-term outcomes such as
obesity and metabolic syndrome in the offspring26
2. Difficulties in performing a cost-utility analysis, mainly due to paucity
of health-related quality of life data for obstetric health states and
uncertainties in combining utility values for mother and child
We are limited by the available utility values for HCV-related health
states. The values that were used in this study were derived from
the published literature and originated from a panel of experts who
used standard techniques to derive the values. Expert opinion may
not reflect the utility values that would be assigned by a patient or
the general population.27
One methodologic issue of decision and cost-effectiveness analysis
that we explored deserves mention. It is unclear in models of
pregnant women whether and how to include the utilities related to
the neonate.28
An additional, and indeed unique, feature of perinatal care that has
received far less attention from analysts conducting economic
evaluations surrounds the decision on when to commence
‘counting’ the life of the infant in the calculus. Economic
evaluations of perinatal interventions that directly impact prenatal
life have typically not incorporated fetal losses into composite
measures of health outcome such as LYs or QALYs gained or DALYs
averted. As a consequence, miscarriages and stillbirths have not
commonly been associated with either health gains or losses.
Although the assumption that life commences at birth can be based
upon a particular ethical claim or legal understanding, this is rarely,
if ever, explicitly stated in published economic evaluations29
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The other type of articles (reviews and comments/edito-
rials/letters) mentioned more common issues. Because of
the unspecific character of these qualitative data, this was
not summarised in an analytical theme. Some mentioned
that often, not all major and relevant health outcomes were
considered13 or that studies differed in outcome measure
used, even when studying the same interventions.14 Overall,
articles recognised that EE in obstetric care is complicated
because outcomes of mother and child are interlinked and
that standardisation in this specific area is lacking.
Integrating the data: challenges of EEs in obstetric
care
Integrating the data from the scoping reviews and the
interviews with international experts, resulted in the identi-
fication of two major challenges and highlighted possible
ways to move forward.
Challenge 1: Deciding on the correct time horizon
The experts propose that based on clinical evidence, clini-
cians and health economists can jointly decide on the
appropriate time horizon for the analysis. This does not
necessarily entail a lifetime horizon but deviating from this
should be clearly justified.
Many authors mentioned the lack of and uncertainty
about long-term data on health effects of obstetric inter-
ventions as the main reason for choosing a shorter than
lifetime horizon. Experts acknowledged that the long-term
follow-up data of clinical trials are more valid than extrap-
olating outcomes over longer time periods. However, long-
term data may not always be available, and obtaining it not
always feasible, also due to the fact that funders usually
have short ‘time horizons’ for grants and will not finance
long-term follow-up. Suggestions to deal with this problem
include using other sources of data and considering new
technological options (e.g. with social media) to facilitate
gathering follow-up data on long-term health effects.
Challenge 2: Performing a cost-utility analysis
TBEEs and MBEEs that did not perform a CUA, and there-
fore do not use QALYs as their effect measure, mentioned
the lack of data on health-related quality of life (HrQoL)
for obstetric and follow-up health states as the main reason
for non-adherence to the guidelines. With no reliable
short-term and long-term HrQoL data available, clinical
outcome measures were used to determine cost-effective-
ness.
Researchers of TBEEs attempting to collect their own
HrQoL data during clinical trials or cohort studies, using
standardised instruments such as the EQ5D, pointed out
more challenges using QALYs in obstetric care. They men-
tioned that obstetric interventions often happen within a
restricted period, such as the induction of labour, which
causes the effects to be too small to result in QALY differ-
ences.
Due to paucity of HrQoL data, MBEEs that performed a
CUA needed to use best available estimates from the litera-
ture or by consulting experts. Many of these studies con-
sidered these alternative methods of obtaining utility values
a weakness of their analysis and therefore stressed the need
for accurate data on quality of life in mothers and infants
experiencing obstetric interventions.
Researchers also struggled with combining health effects
for mother and child. They raised such questions as
whether both maternal and fetal effects should be mea-
sured, whether these effects should be combined in one
outcome measure, whether the effects in mother and child
should be weighted equally, whether utility values of neo-
nates should be included in the maternal health state and
whether utility values of other family members should be
considered as well.
In the interviews, experts indicated that QALYs might
not be an optimal measure, but nonetheless stressed the
importance of QALYs as being at least a good generic out-
come measure. Although applying the quality of life con-
cept in obstetric care poses challenges, the experts
mentioned that when doing a trial, a quality of life measure
should be included. As the commonly used instruments
may not be suitable in all circumstances, the experts sug-
gested the use of a core outcome set for obstetrics as well
as the development of other instruments. For the involved
children, measurement of quality of life should start at
birth. This could be achieved by asking different sources to
indicate the health level (parents, but also clinicians and
nurses) and to value these health states.
Experts mentioned that not every cost-effectiveness anal-
ysis (CEA) of an obstetric intervention has to include out-
comes in both mother and child, as long as researchers
base their decision on clinical evidence, and clearly justify
and report their choices. However, when both mother and
child are considered, the experts favoured reporting QALYs
for mother and child both separately and combined. They
argued that if an intervention results in QALY gains for the
child but QALY losses for the mother, only reporting the
combined outcomes would not be appropriate. Also
including other family members might make sense,
depending on the situation, according to the experts.
Discussion
Main findings
Analysis of 184 EEs of obstetric interventions suggested
main areas of current challenges in this field and identified
reasons for non-adherence to guidelines. Researchers
seemed to encounter most difficulties with using the cor-
rect time horizon and performing a CUA. Most important
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reasons for non-adherence appeared to relate to paucity of
long-term health data, difficulties in obtaining data on util-
ity values of health states and combining health effects of
mother and child.
Strengths and limitations
To our knowledge, this was the first study that has qualita-
tively assessed reasons for non-adherence to EE guidelines
in obstetric care. Although unique in its field, using a scop-
ing review design and qualitative research methods, some
limitations need mentioning.
First, because of the scoping character, the amount of
included studies can reach considerable numbers.10 To
restrict the number of articles, articles (n = 63) about pre-
natal screening for fetal abnormalities were excluded, espe-
cially as other reviews15,16 already discussed the
methodological challenges related to EE of prenatal screen-
ing interventions. Furthermore, we focussed on CEA/CUA,
although cost-benefit and cost-minimisation analyses are
also forms of health EEs. However, CEA/CUA make up the
major part of EEs, and guidelines also focus on these types
of analyses.
Second, a scoping study can include all types of literature
and study designs, which makes exact replication of this
type of review more challenging than in a systematic review
conducted according to very strict guidelines.17 To reduce
potential bias in the review process, inclusion of studies
was done according to a pre-specified and detailed proto-
col. To confirm correct adherence to the inclusion proto-
col, a random sample of articles was double-checked by a
second reviewer during the inclusion process.
Third, several methods can be used for qualitative analy-
sis. This study used the ‘thematic synthesis’ method. This
method is considered easily applicable, but the flexibility of
this method might cause different researchers to choose
different aspects of the data as their focus. During our
qualitative analysis, two main analytical themes arose.
These themes were further explored in the semi-structured
interviews. This may have caused the experts to focus espe-
cially on these pre-set themes. To avoid missing other chal-
lenges, all experts were explicitly invited to think about and
discuss other challenges of EEs in obstetric care.
In this study, we focused on the specific methodological
challenges related to performing EEs in the field of obstet-
rics. Of course, the more general methodological challenges
related to EEs (e.g. large sample size needed to find a sig-
nificant QALY difference) add to the complexity. More-
over, we did not focus on cost, modelling methods and
equity considerations, as these were considered less obstet-
rics-specific, which was confirmed by our text search for
information and argumentation on non-adherence to
guidelines.
Non-adherence to guidelines found in our study can also
partly be caused by individual studies originating from
another jurisdiction or published before the guidelines cho-
sen in this study were published. However, the majority of
the EEs included are from countries of which we included
the guideline. Furthermore, restricting our analysis to the
80 publications since 2013, revealed comparable or even
lower adherence rates (e.g. 55% for type of analysis and
35% for time horizon).
Interpretation
Whereas previous studies8,9 have focused on assessing the
methodological quality of individual EEs in obstetric care
using a checklist (e.g. CHEERS Statement),18 no in-depth
analysis was performed of what makes adherence to guide-
lines difficult. This makes comparisons with our results dif-
ficult.
Our study showed that included EEs varied widely in
terms of chosen time horizon. Although 49% of the
included studies used a lifetime horizon, the rest did not.
An earlier review focusing on the methodological quality of
EEs in obstetrics and gynaecology between 1997 and 20098
also highlighted the great variety in applied time horizon,
with 29% of the studies using a lifetime horizon.
The most important reason to choose a different time
horizon was the lack of and uncertainty regarding long-
term data on health effects of obstetric interventions. Teune
et al.19 evaluated the follow up after large obstetric clinical
trials. They found that only 16% included follow up of the
children after discharge from the hospital. This aligns with
our findings, indicating that researchers may lack the clini-
cal data to comply with recommendations on applying a
lifetime horizon.
Next to the major issue of paucity of HrQoL data, we
also found that researchers question the sensitivity and
applicability of the QALY measure for obstetric health
states. Petrou and Henderson20 also point out that current
utility measures, such as the EQ5D, lack sensitivity for sub-
tle changes in health caused by perinatal interventions. This
is why G€artner et al.21 started developing a birth-specific
utility questionnaire. Besides the challenges in adhering to
common guidelines regarding time horizon and in obtain-
ing required health-related quality of life data, one of the
unique features of obstetric care is that outcomes in both
mothers and children are relevant. This causes additional
complications in performing EEs. D’Souza et al.,22 for
instance, mentioned this ‘mother–fetus dyad’ as a compli-
cating factor when applying decision analytic modelling.
They suggested specific recommendations for clinical deci-
sion analysis studies in perinatology, such as recommenda-
tions on time horizon and including health outcomes of
both mother and fetus.
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As our study showed, EEs in obstetric care come with
several challenges. Current guidelines do not provide
researchers in this area with specific recommendations or
advice on how to deal with these challenges. This may have
increased the heterogeneity in methodological choices in
EEs in obstetrics, which limits their comparability and
jeopardises their methodological quality.
A next step therefore is a broad consultation about how to
deal with these challenges. Although not all issues are easily
solved, this at least will stimulate standardisation of methods,
which increases comparability of studies. This is comparable
to the efforts that have been made to standardise EEs in the
youth sector.23 The results may lead to a set of special recom-
mendations for conducting EEs of obstetric interventions.
These recommendations should complement national and
international guidelines, comparable to the set of recommen-
dations developed in the field of osteoporosis.24
Solving underlying problems that cause non-adherence
should remain a priority. Although financially challenging
and time-consuming, one could think of facilitating clinical
trials to prolong their follow up or establishing a catalogue
of health utility values with data for maternal and neonatal
health states after obstetric interventions, comparable to
the overview of childhood health utilities.25
Conclusion
This study identified ‘type of analysis’, ‘effect measure’ and
‘time horizon’ as items of EE guidelines that frequently are
not complied with in the context of obstetric interventions.
Reasons for non-adherence especially had to do with the
paucity of long-term health and quality of life data in rela-
tion to obstetric interventions, as well as the specific chal-
lenges in measuring and combining quality of life in health
states that involve mother and child. The results of this
study could serve a starting point for a broad consensus
building on how to deal with these challenges in future EEs
in obstetric care.
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